OTCMKTS:GENTY - Gentium Srl Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$56.10Today's RangeN/A52-Week Range$7.26 - $59.25VolumeN/AAverage Volume6,528 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Gentium SpA is a biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company's development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. In February 2014, Jazz Pharmaceuticals PLC acquired the 98% interest in Gentium SpA (Gentium). Receive GENTY News and Ratings via Email Sign-up to receive the latest news and ratings for GENTY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:GENTY Previous Symbol CUSIPN/A Webwww.gentium.com Phone+39-31-5373200 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Gentium Srl (OTCMKTS:GENTY) Frequently Asked Questions What is Gentium Srl's stock symbol? Gentium Srl trades on the OTCMKTS under the ticker symbol "GENTY." Has Gentium Srl been receiving favorable news coverage? Media coverage about GENTY stock has been trending somewhat positive this week, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Gentium Srl earned a media sentiment score of 1.1 on InfoTrie's scale. They also gave headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are Gentium Srl's key executives? Gentium Srl's management team includes the folowing people: Khalid Islam Ph.D., Chairman of the Board, Chief Executive Officer, Interim Scientific Director (Age 61)Salvatore Calabrese, Chief Financial Officer, Chief Operating Officer (Age 44)Carin Heringa, Senior Vice President, Scientific Director (Age 52)Marco Maria Brughera, Director (Age 60)Laura Ferro Ph.D., Director (Age 62)Gigliola Bertoglio CPA, Independent Director (Age 79)Bobby W. Sandage Jr., Ph.D., Independent Director (Age 63)Elmar J. Schnee, Independent Director (Age 57) How do I buy shares of Gentium Srl? Shares of GENTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Gentium Srl's official website? The official website for Gentium Srl is https://www.gentium.com/. How can I contact Gentium Srl? Gentium Srl's mailing address is Piazza XX Settembre, 2, VILLA GUARDIA, 22079, Italy. The biopharmaceutical company can be reached via phone at +39-31-5373200. MarketBeat Community Rating for Gentium Srl (OTCMKTS GENTY)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 94 (Vote Outperform)Underperform Votes: 59 (Vote Underperform)Total Votes: 153MarketBeat's community ratings are surveys of what our community members think about Gentium Srl and other stocks. Vote "Outperform" if you believe GENTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GENTY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/11/2018 by MarketBeat.com StaffFeatured Article: What are retained earnings?